Related Experiment Video
Updated: Nov 23, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
circFOXO3 protects cardiomyocytes against radiation‑induced cardiotoxicity
Yiming Qiu1, Xianping Xie1, Luhua Lin1
1Department of Cardiology, Fujian Longyan People's Hospital, Longyan, Fujian 364000, P.R. China.
Abstract:
Radiation therapy, one of the major treatment options for cancer, can cause delayed heart damage. The circular RNA (circRNA) circFOXO3 (hsa_circ_0006404) is associated with cancer progression. However, the functions of circFOXO3 in radiation‑induced cardiotoxicity remains unknown. The present study aimed to identify the functions of cirFOXO3 in radiation‑induced cardiotoxicity. The present study established circFOXO3‑knockdown (KD) or ‑overexpressing (OE) cardiomyocytes. Functional assay results showed that KD of circFOXO3 in cardiomyocytes significantly increased DNA damage and apoptosis after radiation. By contrast, OE of circFOXO3 reduced DNA damage and apoptosis rates in response to radiation. Mechanistically, KD of circFOXO3 elevated the levels of Bax, caspase 3 and caspase 7, and decreased Bcl‑2 expression, whereas OE of circFOXO3 decreased Bax, caspase 3 and caspase 7 expression, and increased Bcl‑2 expression. Thus, the present study indicated that circFOXO3 protected cardiomyocytes from radiation‑induced cardiotoxicity by reducing DNA damage and apoptosis. circFOXO3 may be a potential therapeutic target against radiation‑induced cardiotoxicity.
More Related Videos
10:41Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
Published on: January 23, 2021
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Biological Effects of Radiation
Cardiomyopathy II: Dilated Cardiomyopathy